Cheese intake and risk factors for cardiovascular diseases and the metabolic syndrome : with particular reference to Gamalost intake and its effect on blood pressure

The papers included in this thesis are part of a larger project titled “Healthy Cheese” (SUNN OST), with an overall main objective to establish a platform to develop innovative and healthy cheese varieties with reduced fat content, probiotic bacteria and bioactive components preferred by the consumers. More specifically, this PhD work aimed to investigate whether Gamalost, a cheese rich in bioactive peptides, could lower blood pressure in humans. Additionally, this work investigated whether a high intake of saturated fat from cheese had an effect on serum cholesterol levels.